Dr. Ginsburg on Genetic Testing Guidelines for Gynecologic Malignancies

Ophira M. Ginsburg, MSc, MD, FRCPC
Published: Tuesday, Oct 03, 2017



Ophira M. Ginsburg, MSc, MD, FRCPC, director of the High Risk/Cancer Genetics Program at NYU Langone's Perlmutter Cancer Center, discusses genetic testing for patients with gynecologic cancers.

There are many genes that are included in the NCCN guidelines that are followed in genetic clinics, states Ginsburg. These guidelines are important to follow for insurance purposes.

When offered genetic counseling, more patients will be educated on BRCA1/2 genes, Lynch syndrome, and could be qualified for up to 80-gene panels, states Ginsburg.

SELECTED
LANGUAGE


Ophira M. Ginsburg, MSc, MD, FRCPC, director of the High Risk/Cancer Genetics Program at NYU Langone's Perlmutter Cancer Center, discusses genetic testing for patients with gynecologic cancers.

There are many genes that are included in the NCCN guidelines that are followed in genetic clinics, states Ginsburg. These guidelines are important to follow for insurance purposes.

When offered genetic counseling, more patients will be educated on BRCA1/2 genes, Lynch syndrome, and could be qualified for up to 80-gene panels, states Ginsburg.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x